BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Angeletti A, Cantarelli C, Petrosyan A, Andrighetto S, Budge K, D'Agati VD, Hartzell S, Malvi D, Donadei C, Thurman JM, Galešić-Ljubanović D, He JC, Xiao W, Campbell KN, Wong J, Fischman C, Manrique J, Zaza G, Fiaccadori E, La Manna G, Fribourg M, Leventhal J, Da Sacco S, Perin L, Heeger PS, Cravedi P. Loss of decay-accelerating factor triggers podocyte injury and glomerulosclerosis. J Exp Med 2020;217:e20191699. [PMID: 32717081 DOI: 10.1084/jem.20191699] [Cited by in Crossref: 6] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Xu Z, Tao L, Su H. The Complement System in Metabolic-Associated Kidney Diseases. Front Immunol 2022;13:902063. [DOI: 10.3389/fimmu.2022.902063] [Reference Citation Analysis]
2 Gao S, Cui Z, Zhao MH. Complement C3a and C3a Receptor Activation Mediates Podocyte Injuries in the Mechanism of Primary Membranous Nephropathy. J Am Soc Nephrol 2022:ASN. [PMID: 35777783 DOI: 10.1681/ASN.2021101384] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Jiang S, Di D, Jiao Y, Zou G, Gao H, Li W. Complement Deposition Predicts Worsening Kidney Function and Underlines the Clinical Significance of the 2010 Renal Pathology Society Classification of Diabetic Nephropathy. Front Immunol 2022;13:868127. [PMID: 35711407 DOI: 10.3389/fimmu.2022.868127] [Reference Citation Analysis]
4 Tan Z, Si Y, Yu Y, Ding J, Huang L, Xu Y, Zhang H, Lu Y, Wang C, Yu B, Yuan L. Yi-Shen-Hua-Shi Granule Alleviates Adriamycin-Induced Glomerular Fibrosis by Suppressing the BMP2/Smad Signaling Pathway. Front Pharmacol 2022;13:917428. [DOI: 10.3389/fphar.2022.917428] [Reference Citation Analysis]
5 Zhang L, Li W, Gong M, Zhang Z, Xue X, Mao J, Zhang H, Li S, Liu X, Wu F, Shi J, Fu G. C-reactive protein inhibits C3a/C3aR-dependent podocyte autophagy in favor of diabetic kidney disease. FASEB J 2022;36:e22332. [PMID: 35503088 DOI: 10.1096/fj.202200198R] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Rayego-Mateos S, Marquez-Expósito L, Rodrigues-Diez R, Sanz AB, Guiteras R, Doladé N, Rubio-Soto I, Manonelles A, Codina S, Ortiz A, Cruzado JM, Ruiz-Ortega M, Sola A. Molecular Mechanisms of Kidney Injury and Repair. Int J Mol Sci 2022;23:1542. [PMID: 35163470 DOI: 10.3390/ijms23031542] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Dong Q, Li Z, Zhang H, Shu H, Tu Y, Liao Q, Yao L. Serum and Glucocorticoid-Inducible Kinase 3/Nedd4-2 Signaling Pathway Participates in Podocyte Injury by Regulating the Stability of Nephrin. Front Physiol 2022;12:810473. [DOI: 10.3389/fphys.2021.810473] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Angeletti A, Magnasco A, AntonellaTrivelli, Degl'Innocenti LM, Piaggio G, Lugani F, Caridi G, Verrina E, Cravedi P, Ghiggeri GM. Refractory Minimal Change Disease and Focal Segmental Glomerular Sclerosis Treated With Anakinra. Kidney Int Rep 2022;7:121-4. [PMID: 35005321 DOI: 10.1016/j.ekir.2021.10.018] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Borgia P, Papa R, D'Alessandro M, Caorsi R, Piaggio G, Angeletti A, Ceccherini I, Ghiggeri GM, Gattorno M. Kidney Involvement in PSTPIP1 Associated Inflammatory Diseases (PAID): A Case Report and Review of the Literature. Front Med (Lausanne) 2021;8:759092. [PMID: 34778321 DOI: 10.3389/fmed.2021.759092] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Trachtman H, Laskowski J, Lee C, Renner B, Feemster A, Parikh S, Panzer SE, Zhong W, Cravedi P, Cantarelli C, Kulik L, You Z, Satchell S, Rovin B, Liu F, Kalled SL, Holers VM, Jalal D, Thurman JM. Natural antibody and complement activation characterize patients with idiopathic nephrotic syndrome. Am J Physiol Renal Physiol 2021;321:F505-16. [PMID: 34459222 DOI: 10.1152/ajprenal.00041.2021] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Kant S, Kronbichler A, Sharma P, Geetha D. Advances in Understanding of Pathogenesis and Treatment of Immune-Mediated Kidney Disease: A Review. Am J Kidney Dis 2021:S0272-6386(21)00835-0. [PMID: 34508831 DOI: 10.1053/j.ajkd.2021.07.019] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
12 Cantarelli C, Leventhal J, Cravedi P. Complement in Lupus: Biomarker, Therapeutic Target, or a Little Bit of Both? Kidney Int Rep 2021;6:2031-2. [PMID: 34386652 DOI: 10.1016/j.ekir.2021.06.016] [Reference Citation Analysis]
13 Budge K, Dellepiane S, Yu SM, Cravedi P. Complement, a Therapeutic Target in Diabetic Kidney Disease. Front Med (Lausanne) 2020;7:599236. [PMID: 33553201 DOI: 10.3389/fmed.2020.599236] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
14 Detsika MG, Lianos EA. Regulation of Complement Activation by Heme Oxygenase-1 (HO-1) in Kidney Injury. Antioxidants (Basel) 2021;10:60. [PMID: 33418934 DOI: 10.3390/antiox10010060] [Cited by in F6Publishing: 5] [Reference Citation Analysis]